Diamond Hill Capital's ELV Position Overview
Diamond Hill Capital (via Diamond Hill Capital Management, LLC (Investment Advisor)) currently holds 249,722 shares of Elevance Health, Inc. (ELV) worth $96.57 M, representing 0.77% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Diamond Hill Capital has initiated a new position in ELV, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Diamond Hill Capital's Elevance Health (ELV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Elevance Health (ELV) Trades by Diamond Hill Capital
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +249,722 | New Buy | 249,722 | $386.73 |
Diamond Hill Capital's Elevance Health Investment FAQs
Diamond Hill Capital first purchased Elevance Health, Inc. (ELV) in Q2 2026, acquiring 249,722 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Diamond Hill Capital has held Elevance Health, Inc. (ELV) for 1 quarters since Q2 2026.
Diamond Hill Capital's largest addition to Elevance Health, Inc. (ELV) was in Q2 2026, adding 249,722 shares worth $96.57 M.
According to the latest 13F filing for Q2 2026, Diamond Hill Capital's firm, Diamond Hill Capital Management, LLC (Investment Advisor), owns 249,722 shares of Elevance Health, Inc. (ELV), valued at approximately $96.57 M.
As of the Q2 2026 filing, Elevance Health, Inc. (ELV) represents approximately 0.77% of Diamond Hill Capital's publicly disclosed stock portfolio, making it one of their key holdings.
Diamond Hill Capital's peak holding in Elevance Health, Inc. (ELV) was 249,722 shares, as reported at the end of Q2 2026.